CompanyDrug

GenScript’s Legend Biotech Files Type II Variation Application for Carvykti with EMA

CompanyDrug

Takeda and HutchMed’s Fruquintinib Receives Priority Review Status from FDA

Policy / Regulatory

China’s NHC Releases Fourth List of Pediatric Priority Drugs to Boost Development

CompanyDrug

Sichuan Kelun Pharmaceutical to Present Clinical Data on RET Inhibitor and ADC at ASCO

Policy / RegulatoryR&D

Lancet Study Reveals Dalian’s Cancer Survival Rates Compared to US

CompanyDrug

BioRay Pharmaceutical’s LIV-1 Targeted ADC BRY812 Files IND in China

CompanyDrug

Accropeutics Receives HREC Approval for AC-201 Phase I Trial

CompanyDrug

Vcanbio Initiates Phase II Clinical Study for Dental Pulp Stem Cell Injection in Periodontitis

CompanyDrug

Mabwell Bioscience’s 9MW3811 Receives NMPA Approval for Clinical Trials in Oncology and Fibrosis

CompanyDrug

Roche’s Rozlytrek on Track for Priority Review for Pediatric NTRK Fusion Tumor Treatment

CompanyDeals

Zelixir Biotech Secures Over RMB 100 Million in Series A Financing for Synthetic Biology Pipeline

CompanyDeals

PathoAI Secures Tens of Millions in Angel Financing for AI-Powered Pathology Solutions